Aaa Usa Inc patents expiration
1. Lutathera patents expiration
LUTATHERA Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10596278 | AAA USA INC | Stable, concentrated radionuclide complex solutions |
Jul, 2038
(14 years from now) | |
| US10596276 | AAA USA INC | Stable, concentrated radionuclide complex solutions |
Jul, 2038
(14 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-166) | Jan 26, 2025 |
| New Chemical Entity Exclusivity(NCE) | Jan 26, 2023 |
Drugs and Companies using LUTETIUM LU 177 DOTATATE ingredient
NCE-1 date: 26 January, 2022
Market Authorisation Date: 26 January, 2018
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
LUTATHERA family patents
2. Netspot patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9375498 | AAA USA INC | Process for the preparation of complexes of 68Ga |
Aug, 2032
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE-120) | Jun 01, 2023 |
| Orphan Drug Exclusivity(ODE) | Jun 01, 2023 |
| New Chemical Entity Exclusivity(NCE) | Jun 01, 2021 |
Drugs and Companies using GALLIUM DOTATATE GA-68 ingredient
NCE-1 date: 01 June, 2020
Market Authorisation Date: 01 June, 2016
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
NETSPOT family patents